Towards smarter drug combo ideas using AI to map gene functions
Official title: Towards Rational Discovery of Combination Therapies: LLM-Enhanced Gene Function Mapping to Explainable Drug Synergy Prediction
Funded at University of Texas Arlington · NIH-11431174 · Data updated 2026-11-12
A team at a large university is building an AI-powered framework to predict when combining genes or drugs will work best, aiming to speed up choosing effective therapies for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project start | August 6, 2026 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $632,466 |
| NIH project number | 1R01LM015497-01 |
| Project ID | NIH-11431174 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who could benefit from precision medicine approaches in oncology or other diseases where combination therapies are explored.
✕Less likely to help
Patients whose conditions do not involve gene-drug synergy or who are not candidates for combination therapy.
What this research studies
This project uses advanced AI, including transformer models and Bayesian methods, to integrate many data sources and predict how gene interactions and drug combinations may work together. The goal is to create clear, interpretable predictions that can guide future experiments and clinical research. The work focuses on making sense of complex biological data so researchers can identify promising combinations more efficiently.
Why it matters
Potential benefit: If successful, the method could accelerate discovery of effective combination therapies for patients by highlighting the most promising gene-drug pairings.
How similar studies have gone: Preliminary evidence suggests AI-driven integration can improve predictive power, but applying it to gene-drug synergy remains an active area with mixed results.
Where this research is happening
-
University of Texas Arlington
Arlington, United States Active
Researchers
- Principal investigator: Huang, Junzhou — University of Texas Arlington
- Study coordinator: Huang, Junzhou
Related research
Other NIH-funded projects on the same topics.
-
New microfluidic platform to study aging and reproduction in C. elegans
Aims to make studying aging and reproductive biology in C. elegans easier and faster by using a new microfluidic chip that automates how worms are loaded, housed, and imaged.
-
Unlocking how transcriptional regulators influence eye health and disease
A patient-friendly overview of a research project that aims to map how genes control eye health using scalable, advanced data methods.
-
Data-driven look at walkability and safety for older adults
A small, patient-friendly study aims to understand what makes neighborhoods easier or harder to walk for adults aged 21 and older, focusing especially on older adults.
-
How changes to public spaces affect hypertension risk in older adults
changes in everyday public spaces like parks and sidewalks may influence blood pressure in adults 21 and older over time.
-
Improving Teenage Driver Safety through Better Training and Safer Roadways
A teen-focused program tests how strengthening driver training and smarter road design can reduce risky driving and crashes for 15–18-year-olds.
-
Light-activated metal tools to image and treat disease
A researcher team at a university is developing tiny osmium metal compounds that light up and can be activated inside the body to help visualize and control disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.